Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men. (Q43225424)

16 November 2017

title

Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men. (English)

1 reference

16 November 2017

author

Elizabeth Barrett-Connor

6

object named as

Elizabeth Barrett-Connor

1 reference

16 November 2017

Michael D Trifiro

1

1 reference

16 November 2017

J Kellogg Parsons

2

1 reference

16 November 2017

Kerrin Palazzi-Churas

3

1 reference

16 November 2017

Jaclyn Bergstrom

4

1 reference

16 November 2017

Charles Lakin

5

1 reference

16 November 2017

publication date

7 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

105

1 reference

16 November 2017

issue

11

1 reference

16 November 2017

page(s)

1554-1559

1 reference

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Lower urinary tract symptoms increase the risk of falls in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Economic costs of benign prostatic hyperplasia in the private sector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Association between lower urinary tract symptoms and serum levels of sex hormones in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Serum sex hormones and measures of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Lower urinary tract symptoms and its potential relation with late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.09090.X

10.1111/J.1464-410X.2009.09090.X

21 January 2018

Identifiers

DOI

1 reference

release_yubvm6bsirbnxoi4m6azhc4cwa

16 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yubvm6bsirbnxoi4m6azhc4cwa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference